NewGenIvf Group Limited

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, HCA has a market cap of 111.5B. Regarding current trading prices, NIVFW is priced at $0.02, while HCA trades at $492.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas HCA's P/E ratio is 17.59. In terms of profitability, NIVFW's ROE is +0.33%, compared to HCA's ROE of -1.41%. Regarding short-term risk, NIVFW is less volatile compared to HCA. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check HCA's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, THC has a market cap of 17.3B. Regarding current trading prices, NIVFW is priced at $0.02, while THC trades at $198.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas THC's P/E ratio is 12.69. In terms of profitability, NIVFW's ROE is +0.33%, compared to THC's ROE of +0.35%. Regarding short-term risk, NIVFW is less volatile compared to THC. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check THC's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, FMS has a market cap of 13.4B. Regarding current trading prices, NIVFW is priced at $0.02, while FMS trades at $23.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas FMS's P/E ratio is 11.80. In terms of profitability, NIVFW's ROE is +0.33%, compared to FMS's ROE of +0.07%. Regarding short-term risk, NIVFW is less volatile compared to FMS. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check FMS's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, SOLV has a market cap of 12B. Regarding current trading prices, NIVFW is priced at $0.02, while SOLV trades at $69.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas SOLV's P/E ratio is 7.77. In terms of profitability, NIVFW's ROE is +0.33%, compared to SOLV's ROE of +0.37%. Regarding short-term risk, NIVFW is less volatile compared to SOLV. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check SOLV's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, UHS has a market cap of 11.6B. Regarding current trading prices, NIVFW is priced at $0.02, while UHS trades at $179.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas UHS's P/E ratio is 7.88. In terms of profitability, NIVFW's ROE is +0.33%, compared to UHS's ROE of +0.21%. Regarding short-term risk, NIVFW is less volatile compared to UHS. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check UHS's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, ENSG has a market cap of 11.5B. Regarding current trading prices, NIVFW is priced at $0.02, while ENSG trades at $197.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas ENSG's P/E ratio is 34.04. In terms of profitability, NIVFW's ROE is +0.33%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, NIVFW is less volatile compared to ENSG. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check ENSG's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, EHC has a market cap of 10.7B. Regarding current trading prices, NIVFW is priced at $0.02, while EHC trades at $106.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas EHC's P/E ratio is 19.23. In terms of profitability, NIVFW's ROE is +0.33%, compared to EHC's ROE of +0.24%. Regarding short-term risk, NIVFW is less volatile compared to EHC. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check EHC's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, DVA has a market cap of 10B. Regarding current trading prices, NIVFW is priced at $0.02, while DVA trades at $146.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas DVA's P/E ratio is 15.72. In terms of profitability, NIVFW's ROE is +0.33%, compared to DVA's ROE of -1.61%. Regarding short-term risk, NIVFW is less volatile compared to DVA. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check DVA's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, NIVFW is priced at $0.02, while OSH trades at $39.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas OSH's P/E ratio is -17.65. In terms of profitability, NIVFW's ROE is +0.33%, compared to OSH's ROE of +4.64%. Regarding short-term risk, NIVFW is less volatile compared to OSH. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check OSH's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, NIVFW is priced at $0.02, while LHCG trades at $169.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas LHCG's P/E ratio is 82.83. In terms of profitability, NIVFW's ROE is +0.33%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, NIVFW is less volatile compared to LHCG. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check LHCG's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, CHE has a market cap of 5.2B. Regarding current trading prices, NIVFW is priced at $0.02, while CHE trades at $377.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas CHE's P/E ratio is 20.54. In terms of profitability, NIVFW's ROE is +0.33%, compared to CHE's ROE of +0.24%. Regarding short-term risk, NIVFW is less volatile compared to CHE. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check CHE's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, OPCH has a market cap of 4.4B. Regarding current trading prices, NIVFW is priced at $0.02, while OPCH trades at $27.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas OPCH's P/E ratio is 21.97. In terms of profitability, NIVFW's ROE is +0.33%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, NIVFW is less volatile compared to OPCH. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check OPCH's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, MMED has a market cap of 4.3B. Regarding current trading prices, NIVFW is priced at $0.02, while MMED trades at $15.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas MMED's P/E ratio is -16.18. In terms of profitability, NIVFW's ROE is +0.33%, compared to MMED's ROE of -0.07%. Regarding short-term risk, NIVFW is less volatile compared to MMED. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check MMED's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, NIVFW is priced at $0.02, while AMED trades at $100.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AMED's P/E ratio is 39.30. In terms of profitability, NIVFW's ROE is +0.33%, compared to AMED's ROE of +0.09%. Regarding short-term risk, NIVFW is less volatile compared to AMED. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check AMED's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, BKD has a market cap of 3.3B. Regarding current trading prices, NIVFW is priced at $0.02, while BKD trades at $14.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas BKD's P/E ratio is -12.44. In terms of profitability, NIVFW's ROE is +0.33%, compared to BKD's ROE of -5.24%. Regarding short-term risk, NIVFW is less volatile compared to BKD. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check BKD's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, LFST has a market cap of 2.5B. Regarding current trading prices, NIVFW is priced at $0.02, while LFST trades at $6.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas LFST's P/E ratio is 325.50. In terms of profitability, NIVFW's ROE is +0.33%, compared to LFST's ROE of +0.01%. Regarding short-term risk, NIVFW is less volatile compared to LFST. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check LFST's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, NHC has a market cap of 2.5B. Regarding current trading prices, NIVFW is priced at $0.02, while NHC trades at $159.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas NHC's P/E ratio is 21.28. In terms of profitability, NIVFW's ROE is +0.33%, compared to NHC's ROE of +0.12%. Regarding short-term risk, NIVFW is less volatile compared to NHC. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check NHC's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, ACHC has a market cap of 2.4B. Regarding current trading prices, NIVFW is priced at $0.02, while ACHC trades at $26.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas ACHC's P/E ratio is -2.18. In terms of profitability, NIVFW's ROE is +0.33%, compared to ACHC's ROE of -0.39%. Regarding short-term risk, NIVFW is less volatile compared to ACHC. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check ACHC's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, SEM has a market cap of 2B. Regarding current trading prices, NIVFW is priced at $0.02, while SEM trades at $16.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas SEM's P/E ratio is 14.14. In terms of profitability, NIVFW's ROE is +0.33%, compared to SEM's ROE of +0.09%. Regarding short-term risk, NIVFW is less volatile compared to SEM. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check SEM's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, MD has a market cap of 1.9B. Regarding current trading prices, NIVFW is priced at $0.02, while MD trades at $22.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas MD's P/E ratio is 11.66. In terms of profitability, NIVFW's ROE is +0.33%, compared to MD's ROE of +0.20%. Regarding short-term risk, NIVFW is less volatile compared to MD. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check MD's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, NIVFW is priced at $0.02, while AMEH trades at $40.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AMEH's P/E ratio is 39.25. In terms of profitability, NIVFW's ROE is +0.33%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, NIVFW is less volatile compared to AMEH. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check AMEH's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, ADUS has a market cap of 1.7B. Regarding current trading prices, NIVFW is priced at $0.02, while ADUS trades at $93.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas ADUS's P/E ratio is 17.86. In terms of profitability, NIVFW's ROE is +0.33%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, NIVFW is less volatile compared to ADUS. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check ADUS's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, SGRY has a market cap of 1.7B. Regarding current trading prices, NIVFW is priced at $0.02, while SGRY trades at $13.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas SGRY's P/E ratio is -21.48. In terms of profitability, NIVFW's ROE is +0.33%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, NIVFW is less volatile compared to SGRY. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check SGRY's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, ASTH has a market cap of 1.5B. Regarding current trading prices, NIVFW is priced at $0.02, while ASTH trades at $28.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas ASTH's P/E ratio is 63.20. In terms of profitability, NIVFW's ROE is +0.33%, compared to ASTH's ROE of +0.03%. Regarding short-term risk, NIVFW is less volatile compared to ASTH. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check ASTH's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AVAH has a market cap of 1.4B. Regarding current trading prices, NIVFW is priced at $0.02, while AVAH trades at $6.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AVAH's P/E ratio is 6.31. In terms of profitability, NIVFW's ROE is +0.33%, compared to AVAH's ROE of +9.53%. Regarding short-term risk, NIVFW is less volatile compared to AVAH. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check AVAH's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, ARDT has a market cap of 1.3B. Regarding current trading prices, NIVFW is priced at $0.02, while ARDT trades at $9.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas ARDT's P/E ratio is 9.81. In terms of profitability, NIVFW's ROE is +0.33%, compared to ARDT's ROE of +0.10%. Regarding short-term risk, NIVFW is less volatile compared to ARDT. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check ARDT's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, HCSG has a market cap of 1.3B. Regarding current trading prices, NIVFW is priced at $0.02, while HCSG trades at $19.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas HCSG's P/E ratio is 23.49. In terms of profitability, NIVFW's ROE is +0.33%, compared to HCSG's ROE of +0.12%. Regarding short-term risk, NIVFW is less volatile compared to HCSG. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check HCSG's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, NIVFW is priced at $0.02, while BKDT trades at $77.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas BKDT's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to BKDT's ROE of -5.24%. Regarding short-term risk, NIVFW and BKDT have similar daily volatility (0.00).Check BKDT's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, NIVFW is priced at $0.02, while USPH trades at $76.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas USPH's P/E ratio is 54.35. In terms of profitability, NIVFW's ROE is +0.33%, compared to USPH's ROE of +0.03%. Regarding short-term risk, NIVFW is less volatile compared to USPH. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check USPH's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, INNV has a market cap of 1.1B. Regarding current trading prices, NIVFW is priced at $0.02, while INNV trades at $8.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas INNV's P/E ratio is 163.40. In terms of profitability, NIVFW's ROE is +0.33%, compared to INNV's ROE of -0.02%. Regarding short-term risk, NIVFW is less volatile compared to INNV. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check INNV's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, PNTG has a market cap of 1.1B. Regarding current trading prices, NIVFW is priced at $0.02, while PNTG trades at $30.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas PNTG's P/E ratio is 36.49. In terms of profitability, NIVFW's ROE is +0.33%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, NIVFW is less volatile compared to PNTG. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check PNTG's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, TALK has a market cap of 863.8M. Regarding current trading prices, NIVFW is priced at $0.02, while TALK trades at $5.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas TALK's P/E ratio is 129.25. In terms of profitability, NIVFW's ROE is +0.33%, compared to TALK's ROE of +0.07%. Regarding short-term risk, NIVFW is less volatile compared to TALK. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check TALK's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, FSHCX has a market cap of 863.1M. Regarding current trading prices, NIVFW is priced at $0.02, while FSHCX trades at $99.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas FSHCX's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to FSHCX's ROE of N/A. Regarding short-term risk, NIVFW and FSHCX have similar daily volatility (0.00).Check FSHCX's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AMN has a market cap of 724.7M. Regarding current trading prices, NIVFW is priced at $0.02, while AMN trades at $19.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AMN's P/E ratio is -7.56. In terms of profitability, NIVFW's ROE is +0.33%, compared to AMN's ROE of -0.15%. Regarding short-term risk, NIVFW is less volatile compared to AMN. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check AMN's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, EHAB has a market cap of 705.6M. Regarding current trading prices, NIVFW is priced at $0.02, while EHAB trades at $13.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas EHAB's P/E ratio is -154.56. In terms of profitability, NIVFW's ROE is +0.33%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, NIVFW is less volatile compared to EHAB. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check EHAB's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, SNDA has a market cap of 621.8M. Regarding current trading prices, NIVFW is priced at $0.02, while SNDA trades at $34.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas SNDA's P/E ratio is -8.15. In terms of profitability, NIVFW's ROE is +0.33%, compared to SNDA's ROE of -0.81%. Regarding short-term risk, NIVFW is less volatile compared to SNDA. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check SNDA's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, CMPS has a market cap of 552.5M. Regarding current trading prices, NIVFW is priced at $0.02, while CMPS trades at $5.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas CMPS's P/E ratio is -1.87. In terms of profitability, NIVFW's ROE is +0.33%, compared to CMPS's ROE of -3.36%. Regarding short-term risk, NIVFW is less volatile compared to CMPS. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check CMPS's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, NIVFW is priced at $0.02, while MCTA trades at $29.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas MCTA's P/E ratio is 419.36. In terms of profitability, NIVFW's ROE is +0.33%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, NIVFW and MCTA have similar daily volatility (0.00).Check MCTA's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, CYH has a market cap of 427M. Regarding current trading prices, NIVFW is priced at $0.02, while CYH trades at $3.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas CYH's P/E ratio is 0.82. In terms of profitability, NIVFW's ROE is +0.33%, compared to CYH's ROE of -0.32%. Regarding short-term risk, NIVFW is less volatile compared to CYH. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check CYH's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AUNA has a market cap of 409.3M. Regarding current trading prices, NIVFW is priced at $0.02, while AUNA trades at $5.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AUNA's P/E ratio is 14.55. In terms of profitability, NIVFW's ROE is +0.33%, compared to AUNA's ROE of +0.06%. Regarding short-term risk, NIVFW is less volatile compared to AUNA. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check AUNA's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AGL has a market cap of 375.5M. Regarding current trading prices, NIVFW is priced at $0.02, while AGL trades at $22.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AGL's P/E ratio is -0.92. In terms of profitability, NIVFW's ROE is +0.33%, compared to AGL's ROE of -1.17%. Regarding short-term risk, NIVFW is less volatile compared to AGL. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check AGL's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, TOI has a market cap of 334.1M. Regarding current trading prices, NIVFW is priced at $0.02, while TOI trades at $3.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas TOI's P/E ratio is -6.26. In terms of profitability, NIVFW's ROE is +0.33%, compared to TOI's ROE of +7.60%. Regarding short-term risk, NIVFW is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check TOI's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, CCRN has a market cap of 315.8M. Regarding current trading prices, NIVFW is priced at $0.02, while CCRN trades at $9.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas CCRN's P/E ratio is -3.33. In terms of profitability, NIVFW's ROE is +0.33%, compared to CCRN's ROE of -0.24%. Regarding short-term risk, NIVFW is less volatile compared to CCRN. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check CCRN's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, NIVFW is priced at $0.02, while CSU trades at $33.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas CSU's P/E ratio is 0.67. In terms of profitability, NIVFW's ROE is +0.33%, compared to CSU's ROE of -2.10%. Regarding short-term risk, NIVFW is less volatile compared to CSU. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check CSU's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AONC has a market cap of 216.4M. Regarding current trading prices, NIVFW is priced at $0.02, while AONC trades at $7.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AONC's P/E ratio is -8.31. In terms of profitability, NIVFW's ROE is +0.33%, compared to AONC's ROE of +0.06%. Regarding short-term risk, NIVFW and AONC have similar daily volatility (0.00).Check AONC's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AIRS has a market cap of 184.8M. Regarding current trading prices, NIVFW is priced at $0.02, while AIRS trades at $2.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AIRS's P/E ratio is -13.79. In terms of profitability, NIVFW's ROE is +0.33%, compared to AIRS's ROE of -0.14%. Regarding short-term risk, NIVFW is less volatile compared to AIRS. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check AIRS's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, JYNT has a market cap of 128.6M. Regarding current trading prices, NIVFW is priced at $0.02, while JYNT trades at $9.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas JYNT's P/E ratio is -449.00. In terms of profitability, NIVFW's ROE is +0.33%, compared to JYNT's ROE of +0.14%. Regarding short-term risk, NIVFW is less volatile compared to JYNT. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check JYNT's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, NAKAW has a market cap of 116.4M. Regarding current trading prices, NIVFW is priced at $0.02, while NAKAW trades at $15.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas NAKAW's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to NAKAW's ROE of -0.21%. Regarding short-term risk, NIVFW is less volatile compared to NAKAW. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check NAKAW's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, NIVFW is priced at $0.02, while FVE trades at $2.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas FVE's P/E ratio is -5.64. In terms of profitability, NIVFW's ROE is +0.33%, compared to FVE's ROE of -0.15%. Regarding short-term risk, NIVFW is less volatile compared to FVE. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check FVE's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, NIVFW is priced at $0.02, while KDLYW trades at $18.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas KDLYW's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to KDLYW's ROE of -0.21%. Regarding short-term risk, NIVFW is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check KDLYW's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, BTMD has a market cap of 82M. Regarding current trading prices, NIVFW is priced at $0.02, while BTMD trades at $1.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas BTMD's P/E ratio is 2.51. In terms of profitability, NIVFW's ROE is +0.33%, compared to BTMD's ROE of -0.35%. Regarding short-term risk, NIVFW is less volatile compared to BTMD. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check BTMD's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, DCGO has a market cap of 53.2M. Regarding current trading prices, NIVFW is priced at $0.02, while DCGO trades at $0.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas DCGO's P/E ratio is -0.28. In terms of profitability, NIVFW's ROE is +0.33%, compared to DCGO's ROE of -0.71%. Regarding short-term risk, NIVFW is less volatile compared to DCGO. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check DCGO's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, NIVFW is priced at $0.02, while ALR trades at $1.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas ALR's P/E ratio is -1.11. In terms of profitability, NIVFW's ROE is +0.33%, compared to ALR's ROE of -0.15%. Regarding short-term risk, NIVFW is less volatile compared to ALR. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check ALR's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, NIVFW is priced at $0.02, while IMAC trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas IMAC's P/E ratio is -2.27. In terms of profitability, NIVFW's ROE is +0.33%, compared to IMAC's ROE of +1183.61%. Regarding short-term risk, NIVFW is less volatile compared to IMAC. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check IMAC's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, CCEL has a market cap of 29.6M. Regarding current trading prices, NIVFW is priced at $0.02, while CCEL trades at $3.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas CCEL's P/E ratio is -12.23. In terms of profitability, NIVFW's ROE is +0.33%, compared to CCEL's ROE of +0.15%. Regarding short-term risk, NIVFW is less volatile compared to CCEL. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check CCEL's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, NIVFW is priced at $0.02, while CANO-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, NIVFW is less volatile compared to CANO-WT. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check CANO-WT's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, NIVFW is priced at $0.02, while AIH trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AIH's P/E ratio is -2.78. In terms of profitability, NIVFW's ROE is +0.33%, compared to AIH's ROE of +1.16%. Regarding short-term risk, NIVFW is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check AIH's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, NIVFW is priced at $0.02, while CANO trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas CANO's P/E ratio is -0.01. In terms of profitability, NIVFW's ROE is +0.33%, compared to CANO's ROE of -1.49%. Regarding short-term risk, NIVFW is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check CANO's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, NIVFW is priced at $0.02, while FTRP trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas FTRP's P/E ratio is -1.22. In terms of profitability, NIVFW's ROE is +0.33%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, NIVFW is less volatile compared to FTRP. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check FTRP's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AMS has a market cap of 8.6M. Regarding current trading prices, NIVFW is priced at $0.02, while AMS trades at $1.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AMS's P/E ratio is -5.65. In terms of profitability, NIVFW's ROE is +0.33%, compared to AMS's ROE of -0.06%. Regarding short-term risk, NIVFW and AMS have similar daily volatility (0.00).Check AMS's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, PIII has a market cap of 8.1M. Regarding current trading prices, NIVFW is priced at $0.02, while PIII trades at $2.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas PIII's P/E ratio is -0.05. In terms of profitability, NIVFW's ROE is +0.33%, compared to PIII's ROE of +8.94%. Regarding short-term risk, NIVFW is less volatile compared to PIII. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check PIII's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, NIVFW is priced at $0.02, while MODV trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas MODV's P/E ratio is -0.03. In terms of profitability, NIVFW's ROE is +0.33%, compared to MODV's ROE of +1.84%. Regarding short-term risk, NIVFW and MODV have similar daily volatility (0.00).Check MODV's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, SYRA has a market cap of 5.8M. Regarding current trading prices, NIVFW is priced at $0.02, while SYRA trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas SYRA's P/E ratio is -3.68. In terms of profitability, NIVFW's ROE is +0.33%, compared to SYRA's ROE of -0.39%. Regarding short-term risk, NIVFW is less volatile compared to SYRA. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check SYRA's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, NIVFW is priced at $0.02, while GBNH trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas GBNH's P/E ratio is -0.06. In terms of profitability, NIVFW's ROE is +0.33%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, NIVFW is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check GBNH's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, NIVFW is priced at $0.02, while RHE trades at $2.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas RHE's P/E ratio is -1.79. In terms of profitability, NIVFW's ROE is +0.33%, compared to RHE's ROE of -0.00%. Regarding short-term risk, NIVFW is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check RHE's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, NIVFW is priced at $0.02, while RHE-PA trades at $0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, NIVFW's ROE is +0.33%, compared to RHE-PA's ROE of -9.49%. Regarding short-term risk, NIVFW is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check RHE-PA's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, TOIIW has a market cap of 4.8M. Regarding current trading prices, NIVFW is priced at $0.02, while TOIIW trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas TOIIW's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to TOIIW's ROE of +7.60%. Regarding short-term risk, NIVFW is less volatile compared to TOIIW. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check TOIIW's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, ATIP has a market cap of 3M. Regarding current trading prices, NIVFW is priced at $0.02, while ATIP trades at $0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas ATIP's P/E ratio is -0.03. In terms of profitability, NIVFW's ROE is +0.33%, compared to ATIP's ROE of +2.05%. Regarding short-term risk, NIVFW is less volatile compared to ATIP. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check ATIP's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, NIVFW is priced at $0.02, while IMACW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas IMACW's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to IMACW's ROE of +1.05%. Regarding short-term risk, NIVFW is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check IMACW's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, MNDR has a market cap of 740K. Regarding current trading prices, NIVFW is priced at $0.02, while MNDR trades at $0.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas MNDR's P/E ratio is -0.35. In terms of profitability, NIVFW's ROE is +0.33%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, NIVFW is less volatile compared to MNDR. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check MNDR's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, CCM has a market cap of 583.9K. Regarding current trading prices, NIVFW is priced at $0.02, while CCM trades at $4.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas CCM's P/E ratio is -0.73. In terms of profitability, NIVFW's ROE is +0.33%, compared to CCM's ROE of +0.04%. Regarding short-term risk, NIVFW is less volatile compared to CCM. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check CCM's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, TALKW has a market cap of 359K. Regarding current trading prices, NIVFW is priced at $0.02, while TALKW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas TALKW's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to TALKW's ROE of +0.07%. Regarding short-term risk, NIVFW is less volatile compared to TALKW. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check TALKW's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, BACK has a market cap of 208.2K. Regarding current trading prices, NIVFW is priced at $0.02, while BACK trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas BACK's P/E ratio is -0.02. In terms of profitability, NIVFW's ROE is +0.33%, compared to BACK's ROE of +1.05%. Regarding short-term risk, NIVFW is less volatile compared to BACK. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check BACK's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, NVOS has a market cap of 69.1K. Regarding current trading prices, NIVFW is priced at $0.02, while NVOS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas NVOS's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to NVOS's ROE of -0.81%. Regarding short-term risk, NIVFW and NVOS have similar daily volatility (0.00).Check NVOS's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, PIIIW has a market cap of 17.7K. Regarding current trading prices, NIVFW is priced at $0.02, while PIIIW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas PIIIW's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to PIIIW's ROE of +8.94%. Regarding short-term risk, NIVFW is less volatile compared to PIIIW. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check PIIIW's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, IONM has a market cap of 1.6K. Regarding current trading prices, NIVFW is priced at $0.02, while IONM trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas IONM's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to IONM's ROE of +5.28%. Regarding short-term risk, NIVFW is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check IONM's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, TLMD has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while TLMD trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas TLMD's P/E ratio is -1.60. In terms of profitability, NIVFW's ROE is +0.33%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, NIVFW is less volatile compared to TLMD. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check TLMD's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, NFH has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while NFH trades at $11.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas NFH's P/E ratio is -19.75. In terms of profitability, NIVFW's ROE is +0.33%, compared to NFH's ROE of -0.06%. Regarding short-term risk, NIVFW is less volatile compared to NFH. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check NFH's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, SLHG has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while SLHG trades at $0.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas SLHG's P/E ratio is -1.48. In terms of profitability, NIVFW's ROE is +0.33%, compared to SLHG's ROE of N/A. Regarding short-term risk, NIVFW is less volatile compared to SLHG. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check SLHG's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, AFAM has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while AFAM trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas AFAM's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, NIVFW is less volatile compared to AFAM. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check AFAM's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while SLHGP trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, NIVFW's ROE is +0.33%, compared to SLHGP's ROE of -0.71%. Regarding short-term risk, NIVFW and SLHGP have similar daily volatility (0.00).Check SLHGP's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while ATIP-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, NIVFW is less volatile compared to ATIP-WT. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check ATIP-WT's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, TVTY has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while TVTY trades at $32.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas TVTY's P/E ratio is 19.06. In terms of profitability, NIVFW's ROE is +0.33%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, NIVFW is less volatile compared to TVTY. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check TVTY's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, DVCR has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while DVCR trades at $10.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas DVCR's P/E ratio is 28.34. In terms of profitability, NIVFW's ROE is +0.33%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, NIVFW is less volatile compared to DVCR. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check DVCR's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while DCGOW trades at $1.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas DCGOW's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to DCGOW's ROE of -0.71%. Regarding short-term risk, NIVFW is less volatile compared to DCGOW. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check DCGOW's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, HNGR has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while HNGR trades at $18.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas HNGR's P/E ratio is 19.71. In terms of profitability, NIVFW's ROE is +0.33%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, NIVFW is less volatile compared to HNGR. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check HNGR's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, KND has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while KND trades at $9.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas KND's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to KND's ROE of -0.53%. Regarding short-term risk, NIVFW is less volatile compared to KND. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check KND's competition here

NIVFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 30.2K. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, NIVFW is priced at $0.02, while TLMDW trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of N/A, whereas TLMDW's P/E ratio is N/A. In terms of profitability, NIVFW's ROE is +0.33%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, NIVFW is less volatile compared to TLMDW. This indicates potentially lower risk in terms of short-term price fluctuations for NIVFW.Check TLMDW's competition here